Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
ESS-1
Cat.No.: CSC-C0490
Species: Human
Source: endometrial stromal sarcoma
Morphology: adherent cells growing in monolayers, in some regions in multilayers
- Specification
- Q & A
- Customer Review
Immunology: cytokeratin +, cytokeratin-7 (+), cytokeratin-8 -, cytokeratin-17 (+), cytokeratin-18 +, cytokeratin-19 -, desmin -, endothel -, EpCAM -, neurofilament -, vimentin
No, cell viability assays can be used with various cell types, including mammalian cells, microbial cells, and plant cells, allowing researchers to study different biological systems.
Ask a Question
Average Rating: 5.0 | 1 Scientist has reviewed this product
Invaluable
The retinoblastoma cells we obtained from Creative Bioarray have been highly valuable in our studies on treatment resistance mechanisms. Their behavior closely mimics the clinical scenario, allowing us to identify novel approaches to overcome drug resistance.
09 Dec 2022
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: Species: human, Caucasian male 51 years old;
Tumor: fibrosarcoma;
Derived from: metastasis to lung
Description: Species: human, Caucasian female 6 years old;
Tumor: rhabdomyosarcoma;
Derived from: TE671 (described as medulloblastoma, then confirmed as rhabdomyosarcoma, probably identical to RD).
Description: Established from a chemotherapy-resistant tumor sample obtained from the left knee of a 10-year-old boy with anaplastic osteoblastic sarcoma (Rosen grade IIB) in 1989
Description: Established from the recurrence of a dedifferentiated chondrosarcoma (grade III) of the muscle of the thigh from a 76-year-old man in 1989; tumorigenic chondrosarcomatous differentiation of xenografted tumor
Description: Established from the bone marrow metastasis of a 17-year-old man with undifferentiated (standard classification) or unclassified (Palmer classification) alveolar rhabdomyosarcoma; cells were described as carrying a p53 mutation, expressing high levels of both myogenin and myoD, and expressing the Pax3/FKHR fusion protein secondary to the t(2;13)(q35;q14) translocation
